Spots Global Cancer Trial Database for donor apheresis
Every month we try and update this database with for donor apheresis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer | NCT00005785 | Hematologic Neo... HIV Infection | GCSF Mobilized ... | - | National Institutes of Health Clinical Center (CC) | |
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS | NCT00025662 | Graft vs Host D... Myelodysplastic... Leukemia Leukemia, Myelo... Leukemia, Myelo... Leukemia, Lymph... Lymphoma Lymphoma, Mantl... Lymphoma, Non-H... Hodgkin Disease | RFT5-SMPT-dgA Isolex system | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath | NCT00580034 | Lymphoma Myeloma Leukemia Myelodysplasia Solid Tumors | Campath Purged ... Donor Apheresis | 17 Years - | Duke University | |
Stem Cell Transplantation to Treat Systemic Mastocytosis | NCT00006413 | Mastocytosis | Stem cell trans... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS | NCT00025662 | Graft vs Host D... Myelodysplastic... Leukemia Leukemia, Myelo... Leukemia, Myelo... Leukemia, Lymph... Lymphoma Lymphoma, Mantl... Lymphoma, Non-H... Hodgkin Disease | RFT5-SMPT-dgA Isolex system | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath | NCT00580034 | Lymphoma Myeloma Leukemia Myelodysplasia Solid Tumors | Campath Purged ... Donor Apheresis | 17 Years - | Duke University | |
Stem Cell Transplantation to Treat Systemic Mastocytosis | NCT00006413 | Mastocytosis | Stem cell trans... | 2 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies | NCT00001748 | Graft vs Host D... Hematologic Neo... Lymphoma Myelodysplastic... Myeloid Leukemi... | Peripheral bloo... | - | National Institutes of Health Clinical Center (CC) | |
The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood Cancers | NCT00001873 | Chronic Lymphoc... Graft vs Host D... Hematologic Neo... Multiple Myelom... Myelodysplastic... | Isolex 300i plu... | 10 Years - 55 Years | National Institutes of Health Clinical Center (CC) | |
Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia | NCT00001623 | Graft vs Host D... Hematologic Neo... Leukemia Multiple Myelom... Myelodysplastic... | Allogeneic Bone... | 10 Years - 55 Years | National Institutes of Health Clinical Center (CC) |